WallStreetZenWallStreetZen

NASDAQ: RDHL
Redhill Biopharma Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

RDHL past revenue growth

How has RDHL's revenue growth performed historically?
Company
-89.43%
Industry
10.04%
Market
17.15%
RDHL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RDHL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RDHL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RDHL earnings and revenue history

Current Revenue
$6.5M
Current Earnings
$23.9M
Current Profit Margin
366.2%

RDHL Return on Equity

Current Company
-103.2%
Current Industry
15.4%
Current Market
188%
RDHL's Return on Equity (-103.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RDHL announces earnings.

RDHL Return on Assets

Current Company
26.3%
Current Industry
3.4%
RDHL is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RDHL Return on Capital Employed

Current Company
331.98%
Current Industry
5.1%
RDHL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RDHL vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RDHL$6.53M$14.62M$23.92M-4.82%N/A
TLPH$651.00k-$17.95M-$18.40M-21.26%N/A
HUGE$0.00-$11.32M-$13.16MN/AN/A
KALA$0.00-$35.91M-$42.20M-100.00%N/A
AYTU$98.50M-$8.45M-$18.00M+83.31%N/A
View Top Pharmaceutical Stocks

RDHL earnings dates

Next earnings date
Jun 10, 2024

Redhill Biopharma Earnings & Revenue FAQ

What were RDHL's earnings last quarter?

On Invalid Date, Redhill Biopharma (NASDAQ: RDHL) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Redhill Biopharma earnings for the quarter were N/A. In the same quarter last year, Redhill Biopharma's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Redhill Biopharma stock.

What was RDHL's earnings growth in the past year?

As of Q2 2024, Redhill Biopharma's earnings has grown year over year. Redhill Biopharma's earnings in the past year totalled $23.92 million.

What is RDHL's earnings date?

Redhill Biopharma's earnings date is Invalid Date. Add RDHL to your watchlist to be reminded of RDHL's next earnings announcement.

What was RDHL's revenue last quarter?

On Invalid Date, Redhill Biopharma (NASDAQ: RDHL) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Redhill Biopharma's revenue was $12.80 million.

What was RDHL's revenue growth in the past year?

As of Q2 2024, Redhill Biopharma's revenue has grown -89.43% year over year. This is 99.47 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.04%. Redhill Biopharma's revenue in the past year totalled $6.53 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.